Open access · CC-BY
via OpenAlex
Biological ageing and frailty markers in breast cancer patients
Barbara Anna Henk Brouwers, Bruna Dalmasso, Sigrid Hatse, Annouschka Laenen, Cindy Kenis, Evalien Swerts, Patrick Neven, Ann Smeets, Patrick Schöffski, Hans P. M. W. Wildiers
Aging · 2015 · ▲ 60 citations
Abstract
Older cancer patients are a highly heterogeneous population in terms of global health and physiological reserves, and it is often difficult to determine the best treatment. Moreover, clinical tools currently used to assess global health require dedicated time and lack a standardized end score. Circulating markers of biological age and/or fitness could complement or partially substitute the existing screening tools. In this study we explored the relationship of potential ageing/frailty biomarkers with age and clinical frailty. On a population of 82 young and 162 older non-metastatic breast cancer patients, we measured mean leukocyte telomere(definition) length and plasma levels of interleukin-6 (IL-6), regulated upon activation, normal T cell expressed and secreted (RANTES), monocyte chemotactic protein 1 (MCP-1), insulin-like growth factor 1 (IGF-1). We also developed a new tool to summarize clinical frailty, designated Leuven Oncogeriatric Frailty Score (LOFS), by integrating GA results in a single, semi-continuous score. LOFS' median score was 8, on a scale from 0=frail to 10=fit. IL-6 levels were associated with chronological age in both groups and with clinical frailty in older breast cancer patients, whereas telomere length, IGF-1 and MCP-1 only correlated with age. Plasma IL-6 should be further explored as frailty biomarker in cancer patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/aging.100745
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Brouwers, B.A.H., Dalmasso, B., Hatse, S., Laenen, A., Kenis, C., Swerts, E., Neven, P., Smeets, A., Schöffski, P., & Wildiers, H.P.M.W. (2015). Biological ageing and frailty markers in breast cancer patients. <em>Aging</em>. https://doi.org/10.18632/aging.100745
Vancouver
Brouwers BAH, Dalmasso B, Hatse S, Laenen A, Kenis C, Swerts E, et al. Biological ageing and frailty markers in breast cancer patients. Aging. 2015. doi:10.18632/aging.100745.
BibTeX
@article{barbara2015Biolog,
title = {Biological ageing and frailty markers in breast cancer patients},
author = {Barbara Anna Henk Brouwers and Bruna Dalmasso and Sigrid Hatse and Annouschka Laenen and Cindy Kenis and Evalien Swerts and Patrick Neven and Ann Smeets and Patrick Schöffski and Hans P. M. W. Wildiers},
journal = {Aging},
year = {2015},
doi = {10.18632/aging.100745},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Mechanisms of Ageing and Development 2026
Open access · CC-BY
3884 Identifying biomarkers of accelerated ageing in cancer patients from routine clinical data
Newcastle-upon-Tyne Hospitals NHS Trust 2013
Open access · US-GOV
Assessment of Frailty in Patients With Advanced Hepatocellular Cancers
Vestre Viken Hospital Trust 2024
Open access · US-GOV
INTEgRated Health CARE for Patients With Frailty and Heart Failure (INTERCARE-HF): Evaluation of an Innovation Project
Ju Qiu 2023
Open access · US-GOV
Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools
Ziekenhuis Netwerk Antwerpen (ZNA) 2009
Open access · US-GOV
Impact of Frailty in Senior Cancer Patients: Feasibility and Value of Screening Tools and Geriatric Intervention and Predictive Value of a Screening Tool in Relation to Treatment Outcome
Fundacion Miguel Servet 2024
Open access · US-GOV